Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EAGLE: BL-1020 in Acute Schizophrenia
NCT00567710Phase 2Completed
- Sponsor
- BioLineRx Ltd.
- Start
- Jul 2008
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BL-1020 in schizophrenia, sponsored by BioLineRx Ltd.. Started Jul 2008; status: completed.
02
Drugs
BL-1020
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00567710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00567710.